Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095).

Source:http://linkedlifedata.com/resource/pubmed/id/17245230

J. Acquir. Immune Defic. Syndr. 2007 Apr 15 44 5 540-50

Download in:

View as

General Info

PMID
17245230